Definitive Contract 75F40125C00027
Award Date
6/4/25
Potential Completion Date
8/11/26
Potential Value
$2.2M
Federal Agency
Food and Drug Administration
Awardee
Aneon Brillient, LLC
Ultimate Awardee
Not listed
PSC Category
R699 - Support- Administrative: Other
Federal Contract Vehicle
Set-Aside Type
8(a) Sole Source
Extent Competed
Not Available for Competition
Major Defense Program
Not listed
Pricing Type
Labor Hours
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a direct 8(a) sole source award of a 12-month base and 9-month option, labor hour type contract to Aneon Brillient, LLC for the U.S. Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) to provide professional services. The contract has a ceiling value of $4,277,014.63 and an ultimate completion date of May 31, 2026. Aneon Brillient is a minority-owned, small disadvantaged business certified as an SBA 8(a) joint venture. The company has a history of...
<p>This is a Definitive Contract awarded by the Food and Drug Administration (FDA) to Aneon Brillient, LLC, an 8(a) certified small disadvantaged business. The $2,114,246.96 Labor Hours (LH) contract is for professional services supporting the FDA's Oncology Center of Excellence. The contract has an ultimate completion date of August 11, 2025. As an 8(a) sole source award, this contract is set aside for eligible 8(a) small businesses.</p>
This is a direct 8(a) award of a 12-month, labor-hour type contract to Aneon Brillient, LLC for the U.S. Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) to provide professional services support. The contract has a ceiling value of $3,266,346.36 and does not utilize a set-aside. Aneon Brillient is a minority-owned, small disadvantaged business registered as an 8(a) joint venture that specializes in providing a range of professional services to the FDA,...
The U.S. Food and Drug Administration (FDA) awarded an 8(a) sole source contract to Aneon Brillient, LLC, a minority-owned small disadvantaged business, for CDER science database administration support. The $485,507.74 labor-hour contract has an ultimate completion date of August 13, 2029. Aneon Brillient, LLC specializes in providing professional services to federal agencies, particularly the FDA, in areas such as medical product development, drug evaluation, and policy support. This award is...
This is a $1,479,584.76 sole-source 8(a) contract awarded by the U.S. Food and Drug Administration (FDA) to Aneon Brillient, LLC, a minority-owned and small disadvantaged business. The contract is for Freedom of Information Act (FOIA) support services for the FDA's Center for Biologics Evaluation and Research (CBER). As an 8(a) certified company, Aneon Brillient is able to obtain this single-award, labor-hour contract directly from the FDA without a competitive process. The contract has an...
This award represents a 1-year, $190,357.34 time and materials contract for information technology professional services awarded by the U.S. Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) to Aneon Brillient, LLC, an SBA-certified 8(a) joint venture. The contract supports the Office of Pharmaceutical Quality within CDER. As an 8(a) sole source award, this contract leverages the SBA's business development program to provide specialized IT services to the FDA....
The U.S. Food and Drug Administration (FDA) awarded a $229,132.68 labor-hour purchase order to Aneon Brillient, LLC, an SBA-certified 8(a) joint venture company, to provide webmaster, technical, and creative support to enhance and maintain the Office of Translational and Emerging Technologies' (OTED) online presence. This 8(a) sole source set-aside contract has an ultimate completion date of August 14, 2025. Aneon Brillient, LLC is a minority-owned, small disadvantaged business that...
This is a definitive contract awarded by the U.S. Food and Drug Administration (FDA) to Aneon Brillient, LLC, a Small Business Administration (SBA) certified 8(a) joint venture, for $326,304.48. The contract provides shipping, receiving, printing support, and administrative support services for the FDA's Office of Regulatory Affairs Office of Training, Education, and Development (OTED). The contract is set aside for 8(a) small businesses and has a performance period ending on September 29, 2026....
The U.S. Food and Drug Administration (FDA) awarded a 4-year, labor-hour type contract worth $2,133,514.80 to Aneon Brillient, LLC, a Small Disadvantaged Business and 8(a) Joint Venture. The contract is for medical and scientific writing and editing services to support the FDA's Center for Drug Evaluation and Research (CDER). This award was a direct 8(a) sole source contract and did not have a set-aside designation. Aneon Brillient has a history of providing professional services to the FDA,...
This is a $192,142.38 firm fixed-price purchase order awarded by the U.S. Food and Drug Administration (FDA) to Aneon Brillient, LLC, a minority-owned small disadvantaged business certified as an 8(a) joint venture. The contract is for a Quality Assurance Specialist III position to support the FDA's Center for Drug Evaluation and Research (CDER) and Office of Pharmaceutical Quality (OPQ). The work will be performed in Calverton, Maryland and has an ultimate completion date of August 29, 2025....